SYNTHETIC CATHINONES AND NEW PSYCHOACTIVE SUBSTANCES IN POLAND: EPIDEMIOLOGY, TOXICOLOGY, AND PUBLIC HEALTH IMPACT
Abstract
Introduction and purpose: The rapid emergence and increasing prevalence of synthetic cathinones, a prominent subgroup of new psychoactive substances (NPSs), pose a significant and evolving public health challenge in Poland. These substances, often marketed as “bath salts” or “legal highs,” are chemically related to cathinone, a natural stimulant found in the khat plant, but are synthetically modified to evade existing drug control regulations while producing potent stimulant effects [1] Over recent years, Poland has become a major hub for the production, distribution, and consumption of synthetic cathinones, with large quantities seized annually and numerous clandestine laboratories dismantled [3]. This dynamic and complex illicit market, combined with the chemical diversity and unpredictable toxicity of synthetic cathinones, complicates clinical diagnosis, treatment, and forensic toxicological analysis [2] This study aims to provide a comprehensive overview of the epidemiological trends, toxicological profiles, clinical manifestations, and public health implications of synthetic cathinone intoxications in Poland.
Materials and Methods: Data for this study were primarily obtained from national poison registries, including the SYSTEM FOR MONITORING INFORMATION ON SUBSTITUTE AGENTS AND NEW PSYCHOACTIVE SUBSTANCES (SMIOD), and official reports submitted to the Chief Sanitary Inspectorate (GIS) during 2024 [3]. The dataset encompassed detailed information on demographics, geographic distribution of cases, specific substances involved, observed clinical presentations, and patient outcomes related to intoxication events. Clinical observations were further complemented by robust toxicological analyses of biological samples (blood, urine).
Conclusions: This study unequivocally underscores that synthetic cathinones represent a growing and increasingly complex challenge to public health in Poland, contributing significantly to rising morbidity and mortality rates associated with substance intoxications [2] .The findings highlight the critical need for continuous epidemiological surveillance, enhanced public awareness campaigns (especially tailored to identified seasonal peaks), and improved rapid diagnostic capabilities within clinical settings settings [4]. Effective management of this public health crisis necessitates a deeply integrated, multidisciplinary approach that combines advanced toxicological analysis, clinical expertise, and coordinated public health interventions. Addressing this pervasive issue proactively and adapting to the dynamic nature of the NPS market will be essential to mitigate the profound adverse health and social consequences associated with the widespread use of synthetic cathinones.
References
Kalix P. The pharmacology of khat. Progress in NeuroPsychopharmacology & Biological Psychiatry, 20(7), 1163-1173. https://doi.org/10.1016/0306-3623(84)90156-3
Pieprzyca E. Toxicological Profile Analysis of Poisonings with New Psychoactive Substances from the Synthetic Cathinones Group, 2022. https://doi.org/10.1093/jat/bkab102
Chief Sanitary Inspectorate Report on Poisonings with Substitute Agents or New Psychoactive Substances in Poland for 2024
Gomółka E, Morawska A. Advantages and Disadvantages of Rapid Tests: How to Detect Drugs in a Medical Laboratory? Diagn Lab. 2011; 47(2): 197-203
Liliedahl RE, Davidson JT. The differentiation of synthetic cathinone isomers using GC-EI MS and multivariate analysis. Forensic Chemistry, 2021. https://doi.org/10.1016/j.forc.2021.100349
Zaami S, Giorgetti R, Pichini S, Pantano F, Marinelli E, Busardò FP. Synthetic cathinones related fatalities: an update. European Review for Medical and Pharmacological Sciences. 2018;22(1):268-274. Doi: 10.26355/eurrev_201801_14129
Wojciechowski J. Analysis of Emergency Medical Teams’ Procedures with Children in the Acute Phase of Poisoning with Toxic Substances, 2022. http://dx.doi.org/10.48745/ppm.kmzw-0094
Regulation of the Minister of Health, October 17, 2014, on information exchange systems related to the tasks of the State Sanitary Inspection. https://sip.lex.pl/akty-prawne/dzu-dziennik-ustaw/przeciwdzialanie-narkomanii-17219465/art-30-a)
Schifano F, Albanese A, Fergus S, et al. Mephedrone (4-methylmethcathinone; 'meow meow'): chemical, pharmacological and clinical issues. Psychopharmacology. 2011;214:593-602. https://doi.org/10.1007/s00213-010-2070-x
Silva M, et al. Effects of khat chewing on mood and social behavior: A systematic review. Journal of Ethnopharmacology. https://doi.org/10.5001/omj.2023.46
Kuczyńska KA. Assessment of neurotoxicity of MDPV (3,4-methylenedioxypyrovalerone) administered during the period of development of the central nervous system in mice [doctoral dissertation]. Department of Pharmacodynamics, Department of Biopharmacy, Faculty of Pharmacy, Medical University of Łódź; 2024
Gatch MB, Shetty RA, Sumien N, Forster MJ. Behavioral effects of four novel synthetic cathinone analogs in rodents. Addiction Biology 2021;26(4):e12987. https://doi.org/10.1111/adb.12987
Warrick BJ, Wilson J, Hedge M, et al. Lethal serotonin syndrome after methylone and butylone ingestion. Journal of Medical Toxicology. 2012;8(3):254-257. Doi: 10.1007/s13181-011-0199-6
De la Rosa G, Papaseit E, Hladun O, Poyatos L, Caicedo DA, Argote MC, Martín S, Ventura M, La Maida N, Di Trana A, Graziano S, Pichini S, Farré M, Pérez-Mañá C. Acute pharmacological effects of α-PVP in humans: a naturalistic observational study. Frontiers in Pharmacology. 2025;16:1626692. https://doi.org/10.3389/fphar.2025.1626692
Ikejia C, Sittambalam CD, Camire LM, Weisman D. Fatal intoxication with N-ethylpentylone: a case report. J Med Toxicol. 2018 Oct;14(4):294-298. Doi: 10.1080/20009666.2018.1510711
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). European Drug Report 2024: Trends and Developments. Luxembourg: Publications Office of the European Union; 2024. Available from: https://www.emcdda.europa.eu/publications/edr/trends-developments/2024_en
Addiction Information Service. (2025). Report No. 1 (109). National Institute of Public Health – National Institute of Hygiene, Warsaw, Poland
Więckiewicz G, Smardz J, Wieczorek T, Rymaszewska J, Grychowska N, Danel D, Więckiewicz M. Patterns of synthetic cathinones use and their impact on depressive symptoms and parafunctional oral behaviors. Psychiatria Polska. 2021;55(5):1087–1102. https://doi.org/10.12740/PP/OnlineFirst/115170
Wronikowska O, Budzyńska B. Toxicological profile and structure-activity relationship of new synthetic cathinones. Advances in Biochemistry. 2023;69(1):55-70. https://doi.org/10.18388/pb.2021_493
Ordak MW. Factors Affecting the Effectiveness of Pharmacotherapy in a Group of Patients Abusing Mephedrone and Ephedrone [doctoral dissertation]. Warsaw: Medical University of Warsaw; 2021 https://radydyscyplin.wum.edu.pl/sites/radydyscyplin.wum.edu.pl/files/zalacznik_2_-_autoreferat_habilitacyjny.pdf
Masternak S, Padała O, Karakuła-Juchnowicz H. False-positive drug test results in patients taking psychotropic drugs. A literature review. Psychiatria Polska. 2021;55(2):435-446. https://doi.org/10.12740/PP/113173.
Detection of Drugs in Urine by Immunochemical Methods in Medical Diagnostic Laboratories, Recommendations of the National Chamber of Laboratory Diagnosticians, Warsaw 2021.
Berardinelli D, Taoussi O, Daziani G, et al. 3-CMC, 4-CMC, and 4-BMC Human Metabolic Profiling: New Major Pathways to Document Consumption of Methcathinone Analogues? AAPS J 26, 70 (2024). https://doi.org/10.1208/s12248-024-00940-8.
Creehan KM, Vandewater SA, Taffe MA. Intravenous self-administration of mephedrone, methylone and MDMA in female rats. Neuropharmacology. 2015;92:90-7. https://doi.org/10.1016/j.neuropharm.2015.01.003
Hadlock GC, Webb KM, McFadden LM, et al. 4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse. J Pharmacol Exp Ther. 2011;339(2):530-6. https://doi.org/10.1124/jpet.111.184119
Kuropka P, Zawadzki M, Szpot P. A review of synthetic cathinones emerging in recent years (2019-2022). Forensic Toxicol 41, 25-46 (2023). https://doi.org/10.1007/s11419-022-00639-5
Karila L, Megarbane B, Cottencin O, Lejoyeux M. Synthetic cathinones: a new public health problem. Curr Neuropharmacol. 2015;13(1):12-20. https://doi.org/10.2174/1570159X13666141210224137
Bielecka-Papierz G, Poleszak E, Serafko A. Mephedrone - a synthetic derivative of cathinone. Current Issues in Pharmacy and Medical Sciences, 36(1), 54-64. https://doi.org/10.2478/cipms-2023-0011
Brown H, Pollard KA. Drugs of Abuse: Sympathomimetics. Crit Care Clin. 2021;37(3):487-499. https://doi.org/10.1016/j.ccc.2021.03.002
Adamowicz P, Tokarczyk B, Stanaszek R, Slopianka M. Fatal mephedrone intoxication - A case report. Journal of Analytical Toxicology. 2013;37(1):37-42. https://doi.org/10.1093/jat/bks085
Copyright (c) 2025 Aleksandra Młocek, Adrianna Truszyńska-Zawisza, Karolina Gorczyca, Natalia Sapeda, Zuzanna Romanowska, Aleksandra Białas, Weronika Lusarczyk, Anna Mandziuk
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
